AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
DOLUTEGRAVIR AND LAMIVUDINE in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR AND LAMIVUDINE TABLETS TABLETS | Rwanda FDA-HMP-MA-2236 | CIPLA LIMITED | active | 3 Feb 2030 |
DOLUTEGRAVIR AND LAMIVUDINE — RDA Registration Details
RDA (Rwanda) has 1 registered product containing DOLUTEGRAVIR AND LAMIVUDINE, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track DOLUTEGRAVIR AND LAMIVUDINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.